Alan M Rapoport MD
Headache
Clinical Professor of Neurology, David Geffen School of Medicine at UCLA; Private Practice Neurologist, California Medical Clinic for Headache; Founder and Director-Emeritus of the New England Center for Headache; Founding President of the Headache Cooperative of New England (HCNE) and the Headache Cooerative of the Pacific (HCOP). Past President of the International Headache Society
Join to View Full Profile
317 North Mansfield AvenueLos Angeles, CA 90036
Dr. Rapoport is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alan Rapoport, based in Los Angeles, CA, is a neurology specialist with a subspecialty in headache medicine. He completed his residency in neurology at the Icahn School of Medicine at Mount Sinai and an internship in internal medicine at Maimonides Medical Center. Since 2007, he has been a professor at UCLA Health System - Westwood. Dr. Rapoport has published multiple papers on migraine and headache treatment and has been involved in clinical trials related to migraine prevention and postherpetic neuralgia. He holds a CMS Meaningful Use Stage 1 Certification from Epic Systems Corporation.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1967 - 1970
Maimonides Medical CenterInternship, Internal Medicine, 1966 - 1967
State University of New York Downstate Medical Center College of MedicineClass of 1966
Certifications & Licensure
CA State Medical License 2004 - 2028
CT State Medical License 1971 - 2009
FL State Medical License 1973 - 2007
NY State Medical License 1967 - 2007
American Board of Psychiatry and Neurology Neurology
UCNSHeadache Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Preventive Treatment of Episodic and Chronic Migraine Start of enrollment: 2011 Apr 01
- Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- 5 citationsOptimising combined treatment for migraine and temporomandibular disorders (TMDs).Marcela Romero-Reyes, Simon Akerman, Alan M Rapoport
Cephalalgia. 2025-09-01 - 2 citationsMedication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation.Wanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Auranee Trisataya
The Journal of Headache and Pain. 2025-01-16 - 2 citationsLong-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.Stewart J Tepper, Detlef Albrecht, Jessica Ailani, Louis Kirby, Shannon Strom
CNS Drugs. 2024-12-01
Press Mentions
A Review of Transnasal Cooling for Migraine ReliefJuly 21st, 2025- Neuromodulation Effective for Migraine with and Without AuraJuly 3rd, 2025
- Medication Overuse Headache: A Headache Expert’s TipsApril 30th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
